EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Birdshot chorioretinopathy treated with adalimumab and methotrexate from onset: the value of regular angiographic follow-up

Maaike Buskermolen, Saskia M Rombach, Mirjam E.J. van Velthoven

Journal of Ophthalmology and Eye Disorders · 09.08.2025 · 12 (1)

DOI: 10.52338/joed.2025.4966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ophthalmology and Eye Disorders, online erschienen am 09.08.2025. Verfasst von Maaike Buskermolen und 2 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Birdshot chorioretinopathy (BSCR) is a chronic, bilateral, auto-immune, posterior uveitis. Through this BSCR case, we investigated the value of angiographic follow-up, after starting immunomodulatory therapy (IMT). Case report: Upon BSCR diagnosis, a 46-year-old male patient started IMT (adalimumab + methotrexate). At 8 months, we observed clinical quiescence. Angiographically, we observed complete disappearance of the typical choroidal lesions within the first year, but retinal vasculitis persisted to be present up to 2 years to date. Therefore, we continued IMT.

Conclusions

This BSCR case report shows that, even while treated with intensive IMT with adalimumab from onset and despite apparent clinical remission, regular angiographic follow-up revealed incomplete remission after 2 years, especially the retinal vasculitis component. Therefore, we recommend cautiously tapering of IMT and regular angiography for monitoring.

Zitieren

APA

Buskermolen, M., Rombach, S. M., & Velthoven, M. E. V. (2025). Birdshot chorioretinopathy treated with adalimumab and methotrexate from onset: the value of regular angiographic follow-up. Journal of Ophthalmology and Eye Disorders, 12(1). https://doi.org/10.52338/joed.2025.4966

Vancouver

Buskermolen M, Rombach SM, Velthoven MEV. Birdshot chorioretinopathy treated with adalimumab and methotrexate from onset: the value of regular angiographic follow-up. Journal of Ophthalmology and Eye Disorders. 2025;12(1). doi:10.52338/joed.2025.4966

BibTeX
@article{Buskermolen2025,
  author = {Buskermolen, Maaike and Rombach, Saskia M and Velthoven, Mirjam E.J. van},
  title = {Birdshot chorioretinopathy treated with adalimumab and methotrexate from onset: the value of regular angiographic follow-up},
  journal = {Journal of Ophthalmology and Eye Disorders},
  year = {2025},
  volume = {12},
  number = {1},
  doi = {10.52338/joed.2025.4966}
}
Kostenlos starten →